Safety of extended-release niacin/laropiprant in patients with dyslipidemia
To access this article, please choose from the options below
PII: S1933-2874(10)00049-8
doi:10.1016/j.jacl.2010.02.002
© 2010 Published by Elsevier Inc.
PII: S1933-2874(10)00049-8
doi:10.1016/j.jacl.2010.02.002
© 2010 Published by Elsevier Inc.